What Does The FDA's Breakthrough Designation Mean For Investors?

What Does The FDA's Breakthrough Designation Mean For Investors?

Submitted by admin on August 26, 2013 - 1:28pm
Source: 
Seeking Alpha
News Tags: 
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
Headline: 
What Does The FDA's Breakthrough Designation Mean For Investors?

Do Not Allow Advertisers to Use My Personal information